(Q37306869)

19 August 2017

1 reference

title

Botulinum toxin treatment for overactive bladder: risk of urinary retention (English)

1 reference

19 August 2017

Ahmed M Shaban

1

1 reference

19 August 2017

Marcus J Drake

series ordinal

2

1 reference

19 August 2017

publication date

1 November 2008

1 reference

19 August 2017

published in

Current urology reports

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

445-451

1 reference

Muscarinic receptor antagonists for overactive bladder

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11934-008-0077-1

Early Effect on the Overactive Bladder Symptoms following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity

21 January 2018

1 reference

12 December 2020

Botulinum injections for the treatment of bladder symptoms of multiple sclerosis.

1 reference

12 December 2020

Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics

1 reference

12 December 2020

Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.

1 reference

12 December 2020

Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury

1 reference

12 December 2020

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

12 December 2020

Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience

1 reference

12 December 2020

Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results

1 reference

12 December 2020

In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats.

1 reference

12 December 2020

Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra

1 reference

12 December 2020

European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity

1 reference

12 December 2020

Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents

1 reference

12 December 2020

Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.

1 reference

12 December 2020

Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?

1 reference

12 December 2020

Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence

1 reference

12 December 2020

Botulinum toxin as a new therapy option for voiding disorders: current state of the art.

1 reference

12 December 2020

Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity

1 reference

12 December 2020

Refractory idiopathic urge urinary incontinence and botulinum A injection.

1 reference

12 December 2020

Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?

1 reference

12 December 2020

A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.

1 reference

12 December 2020

Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial

1 reference

12 December 2020

Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction.

1 reference

12 December 2020

Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study

1 reference

12 December 2020

Botulinum toxin and its applications in the lower urinary tract

1 reference

12 December 2020

Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity.

1 reference

12 December 2020

10.1007/S11934-008-0077-1

Identifiers

DOI

1 reference

19 August 2017

1 reference